Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+15.4%
5Y CAGR+21.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+15.4%/yr
vs +31.9%/yr prior
5Y CAGR
+21.7%/yr
Recent deceleration
Acceleration
-16.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.7x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.16B | +14.8% |
| 2024 | $1.01B | +13.5% |
| 2023 | $887.60M | +17.9% |
| 2022 | $752.70M | +29.0% |
| 2021 | $583.30M | +34.6% |
| 2020 | $433.30M | +22.4% |
| 2019 | $354.10M | +42.2% |
| 2018 | $248.93M | +46.5% |
| 2017 | $169.91M | +149.6% |
| 2016 | $68.08M | - |